Torsemide: Effective Edema and Hypertension Management
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.50 | $45.11 (0%) | 🛒 Add to cart |
| 120 | $0.45 | $60.15 $54.13 (10%) | 🛒 Add to cart |
| 180 | $0.39 | $90.22 $70.17 (22%) | 🛒 Add to cart |
| 270 | $0.36 | $135.33 $97.24 (28%) | 🛒 Add to cart |
| 360 | $0.34
Best per pill | $180.44 $121.30 (33%) | 🛒 Add to cart |
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.89 | $53.13 (0%) | 🛒 Add to cart |
| 90 | $0.80 | $79.70 $72.18 (9%) | 🛒 Add to cart |
| 120 | $0.76 | $106.26 $91.22 (14%) | 🛒 Add to cart |
| 180 | $0.72 | $159.39 $129.32 (19%) | 🛒 Add to cart |
| 270 | $0.69 | $239.09 $185.46 (22%) | 🛒 Add to cart |
| 360 | $0.67
Best per pill | $318.78 $242.60 (24%) | 🛒 Add to cart |
Synonyms | |||
Torsemide is a potent loop diuretic indicated for the treatment of edema associated with congestive heart failure, renal disease, or hepatic cirrhosis. It is also approved for the management of hypertension, alone or in combination with other antihypertensive agents. By inhibiting the sodium-potassium-chloride cotransporter in the thick ascending limb of the loop of Henle, torsemide promotes significant diuresis, electrolyte excretion, and reduction of extracellular fluid volume. Its predictable pharmacokinetic profile and bioavailability make it a reliable choice in both inpatient and outpatient settings for clinicians aiming to achieve controlled fluid removal and blood pressure reduction.
Features
- Active ingredient: Torsemide
- Available in oral tablet formulations: 5 mg, 10 mg, 20 mg, 100 mg
- Also available as an injectable solution for intravenous use
- High bioavailability (~80%) with rapid absorption
- Onset of diuretic action within 1 hour orally; peak effect in 1–2 hours
- Duration of action: 6–8 hours
- Excreted primarily via hepatic metabolism (CYP2C9) and renal elimination
- Demonstrated efficacy in reducing extracellular fluid volume and systemic blood pressure
Benefits
- Rapid and effective reduction of edema in congestive heart failure, liver cirrhosis, and renal impairment
- Helps lower blood pressure by reducing plasma volume and peripheral vascular resistance
- Predictable dose-response relationship allowing for individualized titration
- May offer improved potassium-sparing effects compared to some other loop diuretics in certain patient populations
- Supports management of fluid overload, potentially reducing hospitalizations and improving quality of life
- Suitable for long-term use in chronic conditions with appropriate monitoring
Common use
Torsemide is commonly prescribed for the treatment of edema due to congestive heart failure, chronic kidney disease, or hepatic cirrhosis. It is also utilized as monotherapy or as part of a combination regimen for hypertension management. In clinical practice, it may be selected over other loop diuretics in patients requiring a predictable pharmacokinetic profile or those with concerns regarding bioavailablity variations.
Dosage and direction
For edema in congestive heart failure: Initial dose is usually 10–20 mg once daily, orally or IV. Dose may be titrated upward based on clinical response, with maximum single doses typically not exceeding 200 mg.
For hepatic cirrhosis: Start with 5–10 mg once daily concomitantly with an aldosterone antagonist or potassium-sparing diuretic.
For hypertension: Initial dose is 5 mg once daily, adjust to maintenance dose of 5–10 mg daily.
Dosage should be individualized; administer in the morning to avoid nocturia. For IV administration, may be given slowly over 2 minutes; not to exceed 200 mg per dose.
Precautions
Monitor blood pressure, renal function, and electrolytes (especially potassium, sodium, magnesium) periodically. Use with caution in patients with sulfonamide allergy. Risk of ototoxicity, especially with rapid IV administration or concomitant use of other ototoxic drugs. May cause dehydration or hypotension; ensure adequate hydration unless contraindicated. Photosensitivity reactions have been reported. Not recommended during pregnancy unless potential benefit justifies potential risk.
Contraindications
Hypersensitivity to torsemide or any component of the formulation; anuria; patients in hepatic coma or states of severe electrolyte depletion.
Possible side effect
Common: dizziness, headache, polyuria, hyperglycemia, hyperuricemia, hypokalemia, hyponatremia, hypomagnesemia.
Less common: orthostatic hypotension, rash, photosensitivity, hearing impairment, gastrointestinal upset.
Rare: Stevens-Johnson syndrome, pancreatitis, thrombocytopenia.
Drug interaction
May enhance nephrotoxicity with aminoglycosides or other nephrotoxic agents. NSAIDs may reduce diuretic and antihypertensive effects. Enhanced hypotensive effects with other antihypertensives or nitrates. May increase lithium levels. CYP2C9 inhibitors (e.g., fluconazole) may increase torsemide levels. Corticosteroids and amphotericin B may exacerbate electrolyte imbalances.
Missed dose
If a dose is missed, take it as soon as remembered unless it is near the time for the next dose. Do not double the dose. Consult healthcare provider for specific guidance based on individual treatment plan.
Overdose
Symptoms may include dehydration, electrolyte imbalances, hypotension, circulatory collapse. Treatment is supportive and includes electrolyte replacement and volume resuscitation. Hemodialysis is not effective due to high protein binding.
Storage
Store at room temperature (20–25°C), away from moisture, light, and heat. Keep in original container, tightly closed. Keep out of reach of children and pets.
Disclaimer
This information is for educational purposes and does not replace professional medical advice. Always consult a healthcare provider for diagnosis, treatment decisions, and individualized dosing. Do not initiate, adjust, or discontinue medication without medical supervision.
Reviews
“Torsemide has been effective in managing my patients with refractory heart failure edema, offering a consistent response and easier titration compared to furosemide.” – Cardiologist, 12 years experience
“Using torsemide for hypertensive patients with renal impairment has provided predictable control with fewer hospital visits for electrolyte issues.” – Nephrologist
“Patients appreciate once-daily dosing and reduced frequency of hypokalemia compared to other loop diuretics.” – General Practitioner